Anzeige
Mehr »
Login
Mittwoch, 29.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Energiekrise als Chance: Mit dieser Aktie starten Sie ins Börsenjahr 2025 durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0J2R1 | ISIN: NL0000395903 | Ticker-Symbol: WOSB
Stuttgart
28.01.25
21:45 Uhr
173,10 Euro
+2,35
+1,38 %
1-Jahres-Chart
WOLTERS KLUWER NV Chart 1 Jahr
5-Tage-Chart
WOLTERS KLUWER NV 5-Tage-Chart
RealtimeGeldBriefZeit
173,10173,3528.01.
173,05173,3028.01.
GlobeNewswire (Europe)
666 Leser
Artikel bewerten:
(2)

Wolters Kluwer N.V.: Wolters Kluwer shareholders approve appointment of Anjana Harve to the Supervisory Board

Finanznachrichten News

PRESS RELEASE

Wolters Kluwer shareholders approve appointment
of Anjana Harve to the Supervisory Board

Alphen aan den Rijn, the Netherlands - October 28, 2024 - Wolters Kluwer, a global leader in professional information, software solutions, and services, announces that Anjana Harve has been appointed as Member of the Supervisory Board at an Extraordinary General Meeting of Shareholders ("EGM") held today. The appointment is effective immediately and is made for a period of four years, up to and including the Annual General Meeting of Shareholders to be held in 2029.

Ms. Harve is an experienced business leader with extensive IT expertise. She currently serves as Executive Vice President and Chief Information Officer (CIO) at BJ's Wholesale Club, a leading membership warehouse operator. Previously, she held positions as Global CIO at Fresenius Medical Care and Hillrom, as well as Global Head of Commercial Technology Services, Compliance Services, and Information Management at Novartis.

Wolters Kluwer shareholders, participated in person or by proxy, representing a total of 78.91% of the total issued share capital entitled to vote. Detailed voting results will be available on our website at www.wolterskluwer.com/egm.

For more information, visit www.wolterskluwer.comor follow us on LinkedIn, Facebook, YouTubeand Instagram.

###

About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services. Wolters Kluwer reported 2023 annual revenues of €5.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

MediaInvestors/Analysts
Dave Guarino Meg Geldens
Wolters Kluwer
VP, Head of Global Communications
Wolters Kluwer
Investor Relations
t + 1 646 954 8215
dave.guarino@wolterskluwer.com (mailto:dave.guarino@wolterskluwer.com)
ir@wolterskluwer.com (mailto:ir@wolterskluwer.com)


Stefan Kloet
Wolters Kluwer
Associate Director Global Communications
m +316 12 22 36 57
stefan.kloet@wolterskluwer.com (mailto:stefan.kloet@wolterskluwer.com)

Forward-looking Statements and Other Important Legal Information
This report contains forward-looking statements. These statements may be identified by words such as "expect", "should", "could", "shall" and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; conditions created by pandemics; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Elements of this press release contain or may contain inside information about Wolters Kluwer within the meaning of Article 7(1) of the Market Abuse Regulation (596/2014/EU).

Trademarks referenced are owned by Wolters Kluwer N.V. and its subsidiaries and may be registered in various countries.

Attachment

  • 2024.10.28 Shareholders approve appointment of Anjana Harve to the Supervisory Board (https://ml-eu.globenewswire.com/Resource/Download/ab498433-59b4-4fa0-8e0d-e5bc80fa9be1)

© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.